Monday, August 31, 2026

Clorox Company Stock Is 9% Up So Far Today

Clorox Company Stock Is 9% Up So Far Today

The Clorox Company (NYSE: CLX), a prominent player in the global market for consumer and professional products, has seen interesting market activity recently. Their shares experienced an unexpected boost, rising nearly 10% during early trading on Thursday morning. Despite this surge, however, they still trade significantly below their 52-week high levels, underscoring the unpredictability of these shares.

Clorox's Performance and Operations

Clorox operates across various sectors including Health and Wellness, Household, Lifestyle, and International segments. Recently, Clorox experienced a slow trading session, which paralleled with an overall decline on the NYSE index.

Profitability and Investment Returns

The company stands out in terms of profitability with a trailing twelve-month earnings per share of $4.61 and its price to earnings ratio standing at an eye-popping 274.91. This shows investors paying an exorbitant premium for future growth prospects. In addition, its return on equity stands at 22.46% over the past year, indicating strong shareholder return on investments made into Clorox's shares.

Stock Performance Against Moving Averages

The Clorox stock has demonstrated strong relative performance versus moving averages, surpassing both its 50-day and 200-day moving averages. This may signal an upward trend; however, market volatility should always be considered. During Q4, for instance, intraday variation reached 0.88%, showing susceptibility to market shifts.

Potential Return for Investors

Clorox offers investors who seek dividend yield an attractive potential return. Morningstar estimates the company's forward annual dividend yield at 3.04%; their next payment is expected on April 24th 2023.

Revenue Growth

Despite challenging market conditions, Clorox maintained strong annual revenue growth, marked by a 5.9% quarterly rise. This suggests that its diverse portfolio of products continues to generate income.

Future Considerations for Investors

Clorox's stock performance demonstrates its susceptibility to market fluctuations. Despite this exposure, its impressive portfolio, profitability, and revenue growth make it an enticing option for investors. Therefore, investors seeking long-term returns should carefully examine both its individual stock specifics as well as market trends before making their decisions.

More news about Clorox Company (CLX).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI's Trust Gap: Microsoft-Mistral Ecosystem Expansion Meets a Governance Deficit in Agentic Adoption
Microsoft is deepening its AI platform bet through simultaneous moves — expanding its Mistral partnership (Copilot Studio, Foundry, European infrastructure capacity) and deepening enterprise AI governance ties with Manulife — just as independent research (Google Cloud, VentureBeat, Box) shows enterprises racing toward agentic AI adoption (100% planned within two years) while data access and trust in agent decisions lag badly (average 45% data access, only ~half trust agent outputs). The result is a structural mismatch between platform-vendor momentum and enterprise readiness to actually govern and trust the agents being deployed.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
Same entity (Morgan Stanley & Co. LLC), same metric (net_income), same fiscal period (Q1 2026), same observation date (2026-03-31), but vastly different values: $5.567 billion vs. $5.57. These cannot coexist for the same time period. Fact B appears to be a data entry error (possible missing decimal placement: 5.57 should likely be 5,567,000,000 or a per-share figure incorrectly entered as total).
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,257 source documents archived
Query this data → isubstrate.com